Abstract
Paget’s disease of bone was first described in 1876,1 but efficacious and safe medical treatments did not become widely available until nearly 100 years later. To some degree, this delay reflected ignorance of the intrinsic abnormality that produces the characteristic changes in bone. With the emergence of a better understanding of the pathophysiology of Paget’s disease, logical approaches to therapy have become possible. Today, after nearly 20 years of experience with specific antipagetic medications, we have acquired some knowledge of what medical treatments can accomplish, but we are still developing guidelines regarding when, whom, and why to treat.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Paget J: On a form of chronic inflammation of bones. Med Chir Trans 1877: 60: 37–63.
Siris E, Kelsey J, Flaster E, et al: Paget’s disease in the United States: A survey of 700 patients. J Bone Mineral Res 1988; 3 (suppl 1): S93.
Schmidek HH: Neurologic and neurosurgical sequelae of Paget’s disease of bone. Clin Orthop 1977; 127: 70–77.
Nager GT: Paget’s disease of the temporal bone. Ann Otol Rhinol Laryngol 1975; 84 (suppl 22): 1–32.
Herzberg L, Bayliss E: Spinal-cord syndrome due to noncompressive Paget’s disease of bone: A spinal-artery steal phenomenon reversible with calcitonin. Lancet 1980; 2: 13–15.
Howarth S: Cardiac output in osteitis deformans. Clin Sci 1953; 12: 271–275.
Poretta CA, Dahlin DC, Janes JM: Sarcoma in Paget’s disease of bone. J Bone Joint Surg [Am] 1957; 39: 1313–1329.
Jacobs TP, Michelsen J, Polay J, et al: Giant cell tumor in Paget’s disease of bone. Cancer 1979; 44: 742–747.
Singer FR: Paget’s Disease of Bone. New York, Plenum, Medical Book 1977, pp 113–114.
Franck WA, Bress NM, Singer FR, Krane SM: Rheumatic manifestations of Paget’s disease of bone. Am J Med 1974; 56: 592–603.
Siris E, Kelsey J, Flaster E, et al: Environmental exposures and medical histories in Paget’s disease. J Bone Mineral Res 1988; 3 (suppl 1): S93.
Posen S, Bligh PC, Wilkinson M: Paget’s disease of bone and hyperparathyroidism: Coincidence or causal relationship? Calcif Tissue Res 1978; 26: 107–109.
Matkovic V, Apseloff G, Sheppard DR, Gerber N: Use of gallium to treat Paget’s disease of bone: A pilot study. Lancet 1990; 1: 72–75.
ElSammaa M, Linthicum FH Jr, House HP, House JW: Calcitonin as a treatment for hearing loss in Paget’s disease. Am J Otol 1986; 7: 241–243.
Meunier PJ, Chapuy MC, Delmas P, et al: Intravenous disodium etidronate therapy in Paget’s disease of bone and hypercalcemia of malignancy: Effects on biochemical parameters and bone histomorphometry. Am J Med 1987; 82 (suppl 2A): 71–78.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Elsevier Science Publishing Co., Inc.
About this chapter
Cite this chapter
Siris, E.S. (1991). Indications for Medical Treatment of Paget’s Disease of Bone. In: Singer, F.R., Wallach, S. (eds) Paget’s Disease of Bone. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2307-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2307-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2309-9
Online ISBN: 978-1-4684-2307-5
eBook Packages: Springer Book Archive